VANCOUVER, BC / ACCESSWIRE / February 9, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) has appointed Benjamin Asuncion to its Board of Directors. From this position, Mr. Asuncion will serve in capital market advisory and valuation capacities as CVR Medical moves towards market launch.
Benjamin Asuncion has over a decade of experience in the capital markets and resources sector. Mr. Asuncion was at Haywood Securities Inc., a privately owned Canadian brokerage firm, in equity research from 2007 through to 2016. As a research analyst, he covered companies of varying sizes and stages. Prior to joining Haywood, Benjamin was involved in the management of an endowment fund at Simon Fraser University (SFU). Mr. Asuncion holds a Bachelor of Business degree from SFU with concentrations in finance, accounting and management science. Mr. Asuncion currently holds a senior management position with a publicly listed company.
Mr. Asuncion has been granted an aggregate of 200,000 incentive stock options pursuant to the terms of CVR Medical’s stock option plan. Such options are exercisable at the price of $0.43 until February 9, 2022 and are subject to the acceptance of the TSX Venture Exchange. The options, which vest immediately, and the common shares issuable upon exercise will be subject to a four-month hold period expiring on June 9, 2017.
For additional information on the organization, leadership, and current news please visit the newly launched company website www.CVRMed.com
About CVR Medical
CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the “Joint Venture”). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.
For further information contact:
Brisco Capital Partners Corp.
Scott Koyich, President
Telephone: (403) 262-9888